Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Nat Rev Microbiol. 2007 Jul;5(7):540-53.

Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.

Author information

  • 1Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA. mlevine@medicine.umaryland.edu

Abstract

More than 50 years of research has yielded numerous Shigella vaccine candidates that have exemplified both the promise of vaccine-induced prevention of shigellosis and the impediments to developing a safe and effective vaccine for widespread use, a goal that has yet to be attained. This Review discusses the most advanced strategies for Shigella vaccine development, the immune responses that are elicited following disease or vaccination, the factors that have accelerated or impeded Shigella vaccine development and our ideas for the way forward.

PMID:
17558427
[PubMed - indexed for MEDLINE]
PMCID:
PMC3771495
Free PMC Article

Images from this publication.See all images (3)Free text

Figure 1
Figure 2
Figure 3
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Nature Publishing Group Icon for PubMed Central
    Loading ...
    Write to the Help Desk